SECURITIES AND EXCHANGE COMMISSION
Form 8-K
Current Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 14, 2004
QUESTCOR PHARMACEUTICALS, INC.
California | 0-20772 | 33-0476164 | ||
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) | (I.R.S. Employer Identification No.) | ||
3260 Whipple Road Union City, California |
94587 | |||
(Address of Principal Executive Offices) |
(Zip Code) |
Registrants telephone number, including area code: (510) 400-0700
Item 5. Other Events. | ||||||||
SIGNATURE |
This Current Report on Form 8-K is filed by Questcor Pharmaceuticals, Inc., a California corporation (the Company), in connection with the matters described herein.
Item 5. Other Events.
The Companys Board of Directors (the Board) has created the designation of Lead Director and has appointed Brian C. Cunningham, a current member of the Board, to serve as Lead Director until the Companys next annual meeting of shareholders. As Lead Director, Mr. Cunningham will be responsible for coordinating the activities of the Companys independent directors, presiding over regularly scheduled meetings of the Board and acting with the Companys Chairman, President and Chief Executive Officer Charles J. Casamento as a liaison between the Board and investors to provide general board leadership.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: January 14, 2004 | ||||
QUESTCOR PHARMACEUTICALS, INC. | ||||
By: | /s/ CHARLES J. CASAMENTO | |||
Charles J. Casamento | ||||
Chairman, President and Chief Executive Officer |